On Demand Education

GNAQ and GNA11 mutations in uveal melanoma

Dec 2014

Melanoma Res 2014;24:525-34

Shoushtari AN and Carvajal RD

Genomic research in uveal melanoma

Retina Today 2010:67-9

Harbour JW

Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death

Oct 2004

Cancer Res 2004;64:7205-9

Onken MD, Worley LA, Ehlers JP, et al.

Gene expression profiling in uveal melanoma: five-year prospective outcomes and meta-analysis

Jul 2020

Aaberg TM, Covington KR, Tsai T, et al

Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses.

Dec 2014

Aaberg TM, Cook RW, Oelschlager KM, et al.

Next-generation sequencing of uveal melanoma for detection of genetic alterations predicting metastasis.

Apr 2019

Afshar AR, Damato BE, Stewart JM, et al.

Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?

Jan 2020

Binkley EM, Bena JF, Davanzo JM, Hinz C, Boldt HC, Singh AD

Gene expression profiling and PRAME status versus tumor-node-metastasis staging for prognostication in uveal melanoma.

Aug 2018

Am J Ophthalmol 2018;195:154–60

Cai L, Paez-Escamilla M, Walter SD, et al.

Independent prognostic significance of gene expression profile class and largest basal diameter of posterior uveal melanomas.

Feb 2016

Am J Ophthalmol 2016;162:20-7e1.

Correa ZM & Augsburger JJ.

Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes.

Jul 2016

 JAMA Ophthalmol 2016;134(7):728-33.

Decatur CL, Ong, E, Garg, N, et al.

Do largest basal tumor diameter and the American Joint Committee on Cancer’s cancer staging influence prognostication by gene expression profiling in choroidal melanoma.

Aug 2018

Am J Ophthalmol 2018 Nov;195:83–92.

Demirci H, Niziol LM, Ozkurt Z, Slimani N, Ozgonul C, Liu T, et al.

Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and 2 uveal melanomas.

Jul 2016

Oncotarget 2016;7(37): 59209-19.

Field MG, Durante MA, Decatur CL, et al.